RYTHM, Inc. (Nasdaq:RYM) saw its stock price rise sharply, jumping 23% after the company disclosed amendments to its trademark and recipe license agreements with an indirect wholly-owned subsidiary of Green Thumb Industries Inc.
The revised contracts govern the use of a set of brand intellectual property that includes RYTHM, incredibles, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green. Under the new terms, Green Thumb will remit an aggregate fixed annual cash fee to RYTHM of $70 million, with the arrangement taking effect on April 1, 2026. That payment is subject to an annual increase equal to two times a Consumer Price Index-based escalator.
In a statement, Ben Kovler, Chairman and Interim Chief Executive Officer of RYTHM, Inc., said: "These amendments create a framework that strengthens our licensing arrangement with Green Thumb over the long term and supports RYTHM’s Nasdaq listing."
Kovler further emphasized the revenue implications of the amended agreements, saying the company "has established predictable, long-term revenue in a way that is virtually unmatched in the THC space." He added that "as the regulatory and legal landscapes evolve, this structure provides the business and investors with clarity and stability that positions the company well to maximize value for shareholders."
The change represents a move away from the prior compensation method toward a fixed-fee model. RYTHM described the shift as providing more predictable revenue streams tied to its portfolio of consumer-facing brands.
Market reaction to the announcement was immediate, reflected in the one-day 23% rise in RYTHM shares following the news. The company framed the amended agreements as strengthening its commercial relationship with Green Thumb and supporting its broader corporate objectives, including its standing as a Nasdaq-listed company.
Because the disclosure centers on contractual amendments and specified financial terms, the update focuses on the mechanics of the new licensing arrangement - the covered brands, the $70 million fixed annual payment starting April 1, 2026, and the two-times-CPI escalator - and on management’s assessment of the outcome for revenue predictability and investor clarity.